Navigation Links
Monogram Announces Commercial Availability of the HERmark(TM) Breast Cancer Assay
Date:7/8/2008

to our current or planned products; whether we will encounter problems or delays in automating our processes; the ultimate validity and enforceability of our patent applications and patents; the possible infringement of the intellectual property of others; whether licenses to third party technology will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, Merrill Lynch and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to raise sufficient capital in the future, if required. For a discussion of other factors that may cause actual events to differ from those projected, please refer to our most recent annual report on Form 10-K and quarterly reports on Form 10-Q, as well as other subsequent filings with the Securities and Exchange Commission. We do not undertake, and specifically disclaim any obligation, to revise any forward-looking statements to reflect the occurrence of anticipated or unanticipated events or circumstances after the date of such statements.

VeraTag and HERmark are trademarks of Monogram Biosciences, Inc. Herceptin is a registered trademark of Genentech, Inc.

Contacts: Alfred G. Merriweather Jeremiah Hall

Chief Financial Officer Feinstein Kean Healthcare

Tel: 650 624-4576 Tel: 415 677-2700

amerriweather@ jeremiah.hall@

monogrambio.com fkhealth.com


'/>"/>
SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
2. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
3. Monogram Biosciences to Present at The Lazard Capital Markets Fourth Annual Healthcare Conference
4. Monogram Announces First Medicare Payment for Trofile(TM)
5. The Center for Professional Innovation and Education (CfPIE) Announces the First True Certification Program for Document Management Professionals in the Life Sciences
6. The Center for Professional Innovation and Education (CfPIE) Announces a New Global Regulatory Certification Track
7. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
8. NHP Announces Second Quarter Earnings Release Date and Conference Call/Webcast
9. Ventas Announces 2008 Second Quarter Earnings Release Date and Conference Call
10. QuikByte Software, Inc. Announces Changes to Board of Directors and Executive Ranks
11. March of Dimes Announces Nursing Scholarship Recipients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...on Discusses Key Provisions of Legislation, Contin... ST. CHARLES, Ill., Nov. 21 /PRNewswire-USNewswire...ing the landmark Affordable Health Care for Americ...h reform legislation forward, Congress has taken d...re system. Today, AARP hosted an educational foru...
(Date:11/21/2009)... NH based medical credentialing software compan...o form a partnerhsip with Amerinet, Inc., the lead...p will help to transform quality care within the h...s) November 21, 2009 -- ISG Group, LLC, doing busi...eement with Amerinet Inc., a leading national heal...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game,...od Touch. , Mountain View...st popular and addictive game, SplitWords, is now ...s is designed to help banish that ,tip of the tong...brain game challenges the brain by encouraging us...
(Date:11/21/2009)... New Haven Dental Group merges their practice w...CT. , (PRWEB) November 21... partners Dr. David Gibson, Dr. Dean Cloutier, Dr....merged their growing practice with that of esteeme...ckman decided he wanted to retire from dentistry i...
(Date:11/20/2009)...Neurologist Closer to Understanding Brain Wiring a...USNewswire/ -- Dr. Jeremy Schmahmann, Professor of...st at the Massachusetts General Hospital in Boston...ry,s research on the new field of study called "Co...on. ,, Dr. Schmahmann is an award-winning leade...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:New Haven Dental Group Expands Their Vision 2Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...vione,s Technology,Transfer Center (TTC) in New Je...nspection by FDA. The inspection was carried out ...t the US FDA Center for Drug Evaluation and Resear...ral positive,comments on our systems and indicated...
...,s most accurate simulation model for,predicting h...NCETON, N.J., Oct. 29 The Robert Wood,Johnson Fou...million grant,to Archimedes, Inc., developer of a ...ons and policy leaders to determine,reliably and q...
...dern Psychology and Explodes Myths of ,Why ...H, Fla., Oct. 29 Some children have a,genetic pre... to raise than,others. The notion of ,there are no...ears, classical and modern,psychology suggested th...
... tumor tissue, experts say , MONDAY, Oct. 29 (Heal... doesn,t harm the sexual function of prostate canc... Chase Cancer Center in Philadelphia tracked 155 m... the tumor. , "IMRT is revolutionizing how we trea...
...hytherapy) are just as effective at curing prostat...hey are in older men, according to a study present... the American Society for Therapeutic Radiology an...e seeds into the prostate in order to kill the can...
...sing a special type of drug called a pharmaceutica...TGF-beta pathway prevents a serious side effect of...nary fibrosis (scarring of the lungs), thereby ext...n Society for Therapeutic Radiology and Oncologys ...
Other Medicine News:Health News:FDA Inspects Hovione's Technology Transfer Center in New Jersey 2Health News:Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions 2Health News:Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions 3Health News:Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions 4Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Prostate Cancer Radiotherapy Won't Affect Sexual Function 2Health News:Radiation seeds effectively cure prostate cancer in young men 2Health News:Preventing lung scarring may extend lives of lung cancer patients 2
(Date:11/20/2009)... , , NEW YORK, Nov. 20 /PRNewswire/ -...earch report is available in its catalogue. ,, ...ew ,, http://www.reportlinker.com/p0164242/M....html#utm_source=prnewswire&utm_medium=pr&... adhesives and sealants is gaining preeminence in ...
(Date:11/20/2009)... , , HOUSTON, Nov. 20 /PRNewswire-First...nnounced that Dan Moore, President and Chief Execu...icer, will present at the 21st Annual Piper Jaffra... December 2, 2009 at 12:00 PM EST. The conference...mal slides will be presented. Piper Jaffray will ...
(Date:11/20/2009)... , , MEMPHIS, Tenn., Nov. 20 /PRNewswire-...rthopaedics Division is pleased to announce the si...e United States Department of Defense that may lea...tended to revolutionize the treatment of the limbs..., Last year, the Defense Advanced Research Projec...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Women with cystic fibrosis can have safe and successful fertility treatment 50402 1Women with cystic fibrosis can have safe and successful fertility treatment 50402 2Women with cystic fibrosis can have safe and successful fertility treatment 50402 3The European Association for the Study of the Liver renews publishing partnership with Elsevier 50397 1Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 1Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 2Single thawed embryo transfer after PGD does not affect pregnancy rates 9062 3
... Takeda Pharmaceutical Company,Limited (Takeda) an...pment,Center, Inc. submitted a New Drug Applicatio...tration (FDA) for alogliptin (development code:,SY...(DPP-4) inhibitor under,investigation for the trea... Diego, Inc., alogliptin was designed to selective...
...therapy in development for menopausal symptoms, A...mpany,today announced positive results from a pivo...eat postmenopausal women with vulvovaginal atrophy...p line data show that the,multi-center, double-bli...of its co-primary endpoints. The study was conduct...
Other Medicine Technology:Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 2Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 3Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S. 4QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome 2QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome 3
Whelan-Moss T-Tube
Silicone Flat Hubless Drains
Bard® Channel Drain
Spencer Modified Biliary Wire Guides
Medicine Products: